Lambda Biologics will be exhibiting at the MPS World Summit, a global meeting focused on advancing microphysiological systems that replicate human biology through engineered functional models. We will present our functional organoid platforms for disease modeling, immune interaction, and translational research. Join us to explore organoid systems advancing human-relevant biology and mechanism discovery.
- 26 – 29 May 2026
- Walter E. Washington Convention Center, Washington, D.C., United States
- Booth No. 713
MPS World Summit 2026 – Organoids reveal Mechanisms
Microphysiological System (MPS): cell culture systems replicating (patho-) physiology through engineered organ architecture and functionality. This includes especially 3D-(co-)cultures such as organoids, organ-on-chip models, and multi-organ models, as well as the technologies to engineer and analyze these systems.
Lambda Biologics’ Functional Organoid Systems for Human Biology & Mechanism Discovery offer:
- Extensive Biobank of Patient-Derived Cancer Organoids
- Advanced Organoid disease models
- Antibody-Drug Conjugate (ADC) Evaluation Platform using PDOs
- In vitro Tumor Microenvironment with Cytoxic T-Cells
- Fully Customizable Organoid-based Validations & Assays Services
ODISEI – Organoid-based Discovery Platform for Innovative Screening, Evaluation, and Identification
As the life sciences industry continues to seek more predictive and human-relevant research models, organoid technology is rapidly transforming the landscape of microphysiological systems (MPS) and translational research. Compared with conventional 2D cell culture and animal models, organoids better preserve the three-dimensional architecture, cellular heterogeneity, and functional biology of human tissues, enabling researchers to generate more physiologically relevant insights into disease progression, therapeutic response, and toxicity.
The growing adoption of organoid-based microphysiological systems is also aligned with recent regulatory and scientific initiatives focused on improving translational predictability while reducing dependence on animal testing. Advanced organoid models are increasingly recognized as valuable platforms for drug discovery, disease modeling, precision medicine, and next-generation translational research workflows.
To support this rapidly evolving field, Lambda Biologics offers ODISEI (Organoid-based Discovery Platform for Innovative Screening, Evaluation, and Identification) – a comprehensive organoid platform designed to accelerate functional biology studies and translational research across multiple therapeutic areas.
Interested in Organoids – New Approach Methodologies (NAMs)? Meet Lambda Biologics at MPS World Summit 2026!
- Visit us at Booth 713
- Book a meeting in advance to explore collaboration opportunities
Unlocking Human Insight with Organoid Models
Metabolic Diseases | Inflammation | Immunology | Respiratory Disease | Neuroscience | Gastrointestinal Disease
